|Home | About | Journals | Submit | Contact Us | Français|
In 1994 the Canadian Task Force on Preventive Health Care addressed screening for depression in asymptomatic individuals during periodic health assessments.1 On the basis of a review of the literature published to May 1993, the task force concluded that there was fair evidence to exclude screening for depression in the primary care setting (grade D recommendation), because screening instruments did not improve the detection rate or management of depression, particularly among people at high risk, such as those with a family history of depression. The task force recently revisited the topic to determine whether studies published in the past 10 years provided new evidence to recommend that primary care practitioners routinely screen their patients for depression.
In 2002 a systematic review was conducted at the request of the US Preventive Services Task Force to determine whether routine screening improves the detection, treatment and outcome of depression.2,3 This rigorous overview provided the basis for our review to update the Canadian task force's recommendation (Table 1). (A summary of the methods and results of the Canadian task force's review of the US task force's work, the subsequent literature update and the process of arriving at the practice recommendations are available at www.ctfphc.org.)
Depression is frequently encountered in patients in the primary care setting. The 1994/95 National Population Health Survey, a Canadian longitudinal study that included household residents in all provinces, gave a 1-year prevalence rate for major depressive disorder of about 6% among Canadians 18 years of age and older.8 Rates were higher among females than among males and declined in both sexes in the elderly population. Data from a province-wide Canadian community-based survey revealed a 6-month prevalence of depression of 5.9% among children 6–16 years of age.9 Certain subgroups of the Canadian population may be at increased risk for depression. The 2000/01 Canadian Community Health Survey showed that, after controlling for socioeconomic factors, Aboriginal people living off-reserve were 1.5 times more likely than non-Aboriginal people to have experienced an episode of depression in the previous year.10
When making its recommendations (Table 1), the Canadian task force not only considered the effectiveness of screening tools in identifying patients with depression in primary care settings, but it also evaluated the treatment options and outcomes arising from the initial screening process, weighing at each point the potential benefits of intervention against the potential harms (including false-positive results leading to further, unnecessary diagnostic investigation). The systematic review for the US task force2 found good evidence that screening for depression in the primary care setting improves detection rates. Furthermore, when screening is linked to appropriate follow-up and treatment, the overall result, based on a meta-analysis of findings from key studies, was a reduced risk of depression. However, when identification of depressed patients was not linked to follow-up and treatment, there was generally much less improvement in depressive symptoms. Evidence regarding screening adolescents and children is lacking. The available evidence led the US task force to recommend that adults be screened for depression “in clinical practices that have systems in place to assure accurate diagnosis, effective treatment, and follow-up” (grade B recommendation).12 The Canadian task force, after reviewing this body of evidence in the Canadian context, and having ascertained that no new evidence was available, reached the same conclusion (Table 1).
In the studies reviewed, “effective follow-up and treatment” referred to screening programs that were integrated with both feedback to the clinician regarding depression status and a system for managing treatment (antidepressants and psychotherapeutic interventions). Trials that included access to case management or mental health care as part of the system of care were particularly effective in reducing depressive symptoms.
A number of screening tools exist for use in primary care settings. Asking 2 simple questions regarding mood and anhedonia — “Over the past 2 weeks, have you felt down, depressed, or hopeless?” and “Over the past 2 weeks, have you felt little interest or pleasure in doing things?” — may be as effective as longer instruments.12,13 The authors of the systematic review for the US task force calculated that 11 patients with depression would need to be identified through screening to produce 1 additional remission at 6 months. Assuming a 10% prevalence of treatment-responsive depression in primary care, 110 patients would need to be screened to produce this additional clinical remission.2 Although the optimal interval for screening is unknown, the US task force recently stated that “recurrent screening may be most productive in patients with past history of depression, unexplained somatic symptoms, comorbid psychological conditions (such as panic disorder or generalized anxiety), substance abuse, or chronic pain.” 12 A positive screen must be followed by accurate diagnosis, effective treatment and follow-up to ensure that the benefits of screening are realized.
“Integrated programs” as defined in the US and Canadian task force reviews went beyond feedback and included interventions such as education of patients or health care providers or both, access to case management or mental health care and telephone follow-up.12 In deciding whether an integrated program of care for screening and treating depression exists in a community, clinicians need to examine the step-by-step process by which patients go from screening to receiving effective treatment. Given the heterogeneity of the models used in the studies reviewed, it is not possible to recommend a specific primary care-based screening and treatment program for depression. However, the following questions, with examples, may assist clinicians in determining whether integrated care exists in their community:
· Is there a mechanism to ensure that the screening results are reported to the clinician, who can then provide appropriate treatment for depression? What is the process by which the patient proceeds from screening positive to having the diagnosis confirmed to receiving treatment for depression? In the study by Katzelnick and colleagues,5 results of telephone screening were provided to physicians, who saw the patients at an evaluation visit and then for prescheduled follow-up sessions. Providers in the study by Wells and colleagues7 were asked to schedule a visit with patients 2 weeks after the initial screening.
· Is there a clinician trained in the use of antidepressants who will follow up with patients who screen positive? Is there access to psychotherapists trained in approaches effective for the treatment of depression? Evidence-based training in the management and treatment of depression was implemented in the integrated programs reviewed. For example, the study by Wells and colleagues7 provided a 2-day training workshop to clinical leaders (local primary care experts and nurse specialists) as well as educational materials for clinicians and patients. Furthermore, the clinical leaders provided educational sessions, including lectures and ongoing feedback, to clinicians based on medical record audits. Those in the psychotherapy intervention group of this trial had access to therapists who received specific training in cognitive behavioural therapy. In the study by Rost and colleagues,6 both primary care physicians and nurses received brief training in the management of depression that was aimed at enhancing the proportion of patients who completed a course of psychopharmacotherapy or psychotherapy. In each of these studies, there was strong coordination in place and a systematic process that integrated screening with treatment of depression.
Authors of the US task force review suggested that, for increased rates of screening to be translated into improved outcomes, special focus on the course of therapy may be required, “perhaps in the form of a quality improvement effort or other programs systematically designed to provide appropriate care” (page 66).3
The Canadian task force recognizes that such services may not yet be available in all settings. However, on the basis of the evidence, and the burden of this disease, physicians are encouraged to advocate for the implementation of systems to provide linked screening for depression and treatment services in primary care settings.
We thank Jana Fear, former Research Assistant to the task force, for her help in preparing the article.
Contributors: Harriet MacMillan reviewed the evidence and drafted the recommendations and this commentary; Christopher Patterson and Nadine Wathen reviewed the evidence and draft recommendations, critically revised the current article and reviewed subsequent revisions. The Canadian Task Force on Preventive Health Care critically reviewed the evidence and developed the recommendations according to its methodology and consensus development process.
Harriet MacMillan was supported by the Wyeth Canada CIHR Clinical Research Chair in Women's Mental Health. The Canadian Task Force on Preventive Health Care is funded by Health Canada.
This statement is based on the technical report: “Screening for depression in primary care: updated recommendations from the Canadian Task Force on Preventive Health Care,” by Harriet L. MacMillan, Christopher J.S. Patterson and C. Nadine Wathen, with the Canadian Task Force on Preventive Health Care. The full technical report is available online (www.ctfphc.org) or from the task force office (gro.chpftc@ftc).
Correspondence to: Canadian Task Force on Preventive Health Care, 117–100 Collip Circle, London ON N6G 4X8 ; fax 519 858-5112; gro.chpftc@ftc